Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Xenon Pharmaceuticals Inc. (XENE) will release its Q4 and full year 2023 financial results on February 29, 2024, after the U.S. financial markets close. A conference call/webcast will follow at 4:30 pm Eastern Time. Investors can access the live webcast on Xenon's website.
02/22/2024 - 04:01 PM
VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its fourth quarter and full year 2023 financial and operating results after the close of U.S. financial markets on Thursday, February 29, 2024.
Conference Call/Webcast Information:
Date: Thursday, February 29, 2024 Time: 4:30 pm Eastern Time (1:30 pm Pacific Time) Dial-In: (800) 715-9871 or (646) 307-1963 for international callers Conference ID: 9376408
A live audio webcast will be available on the “Investors ” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need. For more information, please visit www.xenon-pharma.com .
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Investor/Media Contact: investors@xenon-pharma.com
When will Xenon Pharmaceuticals Inc. (XENE) report its Q4 and full year 2023 financial results?
Xenon Pharmaceuticals Inc. (XENE) will report its Q4 and full year 2023 financial results on February 29, 2024, after the close of U.S. financial markets.
What time will the conference call/webcast be held for Xenon Pharmaceuticals Inc. (XENE)?
The conference call/webcast for Xenon Pharmaceuticals Inc. (XENE) will be held at 4:30 pm Eastern Time on February 29, 2024.
How can investors access the live audio webcast for Xenon Pharmaceuticals Inc. (XENE)?
Investors can access the live audio webcast on the 'Investors' section of Xenon's website.
What is the conference ID for Xenon Pharmaceuticals Inc. (XENE) conference call/webcast?
The conference ID for Xenon Pharmaceuticals Inc. (XENE) conference call/webcast is 9376408.
Are the listed dates and times for Xenon Pharmaceuticals Inc. (XENE) subject to change?
Yes, the listed dates and times for Xenon Pharmaceuticals Inc. (XENE) are subject to change.
Xenon Pharmaceuticals Inc
XENE Rankings
#3064 Ranked by Stock Gains
XENE Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Canada
City
Burnaby
About XENE
xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes are caused by single-gene defects. by identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases.
